Semi-Annual Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7296856

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-310,773,000 JPY
-462,851,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-312,460,000 JPY
-464,745,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-52,089,000 JPY
-135,032,000 JPY
Net cash provided by (used in) investing activities
-52,089,000 JPY
-129,402,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
919,892,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-10,312,000 JPY
15,222,000 JPY
Net increase (decrease) in cash and cash equivalents
545,029,000 JPY
-578,925,000 JPY
Cash and cash equivalents
2,086,449,000 JPY
1,541,419,000 JPY
1,866,008,000 JPY
2,444,934,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.